Clinical Trial Update: Trial of ProAgio in Advanced/Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This document announces a Phase 1 clinical trial of ProAgio for advanced or metastatic colorectal cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ProAgio

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Advanced Colorectal Cancer, Metastatic Colorectal Cancer | Phase 1 | Status: RECRUITING